Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Moodys
McKinsey
Queensland Health
US Army
Daiichi Sankyo
Julphar
Colorcon
Cantor Fitzgerald
AstraZeneca

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200177

« Back to Dashboard
NDA 200177 describes DIETHYLPROPION HYDROCHLORIDE, which is a drug marketed by Avanthi Inc, Sandoz, Epic Pharma Llc, Watson Labs, Teva, Ucb Inc, Tg United Labs, and Lannett Holdings Inc, and is included in ten NDAs. It is available from nine suppliers. Additional details are available on the DIETHYLPROPION HYDROCHLORIDE profile page.

The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.

Summary for NDA: 200177

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 200177

Suppliers and Packaging for NDA: 200177

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIETHYLPROPION HYDROCHLORIDE
diethylpropion hydrochloride
TABLET;ORAL 200177 ANDA Lannett Company, Inc. 0527-1475 0527-1475-01 100 TABLET in 1 BOTTLE, PLASTIC (0527-1475-01)
DIETHYLPROPION HYDROCHLORIDE
diethylpropion hydrochloride
TABLET;ORAL 200177 ANDA Aidarex Pharmaceuticals LLC 53217-230 53217-230-14 14 TABLET in 1 BOTTLE (53217-230-14)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Jul 18, 2011TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Citi
Baxter
Moodys
Cantor Fitzgerald
Mallinckrodt
Novartis
Cerilliant
Colorcon
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot